Advancing Sickle Cell Treatment: Insights on Gene Therapy, ACCESS Initiative and Advocacy Efforts

In the September President's Message, Dr. Corey Cutler, MD, MPH, shares the importance of Sickle Cell Awareness Month and the progress made in treating the disease, particularly through gene therapy. He mentions the FDA-approved therapies and the upcoming Clinical Education Conference and Gene Therapy Summit. Cutler also discusses the ACCESS Initiative, aimed at reducing treatment barriers for minority populations, and the recent advocacy work during Hill Day. He encourages viewers to support the accelerating Kids Access to Care Act and offers assistance for those who wish to reach out to their local representatives.